Trademark Overview
On Tuesday, June 6, 2023, a trademark application was filed for MEDIPHARM LABS with the United States Patent and Trademark Office. The USPTO has given the MEDIPHARM LABS trademark a serial number of 98030022. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, February 26, 2025. This trademark is owned by MediPharm Labs Inc.. The MEDIPHARM LABS trademark is filed in the Chemical Products, Treatment & Processing of Materials Services, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:
Extraction, purification and processing of cannabis and its cannabinoid constituents for others in the nature of hemp and cannabidiol solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; processing of cannabis and its cannabinoid constituents in the nature of hemp and cannabidiol solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis into cannabis oil
Sale and distribution, namely, retail store services featuring extracted oil from cannabis for cosmetic purposes; exportation and importation agency in the field of dried medical cannabis, edible cannabis and extracted oil from cannabis; wholesale store services featuring cannabis oils and purified cannabis concentrates, active ingredients, distillates, and isolates for further processing into derivative products of non-medicated topicals and vape products containing cannabis for the cannabis industry; all the foregoing in the field of hemp or featuring products containing or for exclusive use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Unprocessed cannabis oils and purified cannabis concentrates, active chemical ingredients, distillates and isolates for use in the manufacture of derivative products in the nature of non-medicated topicals and vape products all containing or for exclusive use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Scientific laboratory services, namely, product formulation development of cannabis and its cannabinoid constituents in the nature of hemp and cannabidiol solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis into cannabis oil